Early initiation of biologic treatment in psoriasis helps prevent the cumulative burden of disease
A large proportion of patients with psoriasis need to switch biologic treatment after initiation. This finding emerges from two RWE studies focusing on plaque psoriasis and psoriatic arthritis.
